XM bietet keine Dienstleistungen für Personen mit Wohnsitz in den Vereinigten Staaten von Amerika an.

XM bietet keine Dienstleistungen für Personen mit Wohnsitz in den Vereinigten Staaten von Amerika an.
G
G

Getinge

Nachrichten

Reuters - vor 4 Tagen

Nordic corporate earnings week ahead

DIARY-Nordic corporate earnings week ahead July 12 (Reuters) - Diary of Nordic (OMXS30-SK, OBX-OS, OMXHPI-HE, OMXC20) corporate earnings for the week ahead NORDIC EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 15-Jul-2024 NTS ORK.OL Orkla ASA Q2 2024 Orkla ASA Earnings Release 17-Jul-2024 05:00 NEL.OL Nel ASA Q2 2024 Nel ASA Earnings Release 18-Jul-2024 NTS TEL.OL Telenor ASA Q2 2024 Telenor ASA Earnings Release 18-Jul-2024 NTS PGS.OL^G24 5088687729 PGS ASA Tgs Newco AS Q2 2024
A
B
D
E
E
E
G
K
K
N
O
P
S
S
T
T
V
W
A
A
S
T
Y
Reuters - vor 2 Wochen

Getinge Extends, Elevates Partnership With Universeum

BRIEF-Getinge Extends, Elevates Partnership With Universeum July 5 (Reuters) - Getinge AB GETIb.ST : EXTENDS AND ELEVATES PARTNERSHIP WITH UNIVERSEUM Further company coverage: [GETIb.ST] (Gdansk Newsroom)
G
Reuters - vor 4 Wochen

Hargreaves Lansdown, Segro, Umicore

EUROPE RESEARCH ROUNDUP-Hargreaves Lansdown, Segro, Umicore June 19 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Hargreaves Lansdown, Segro and Umicore, on Wednesday. HIGHLIGHTS * GEA Group AG G1AG.DE : Jefferies raises to buy from hold * Hargreaves Lansdown HRGV.L : Jefferies cuts to hold from buy * Oxford Instruments OXIG.L : Berenberg raises target price to 2,945p from 2,640p * Segro SGRO.L : Jefferies cuts to hold from buy *
A
A
B
B
B
B
B
B
B
D
D
G
G
G
G
G
H
H
I
K
K
L
M
R
S
S
S
U
U
V
A
S
Reuters - vor 4 Wochen

JPM cuts Getinge's PT by 11% in tough market

BUZZ-JPM cuts Getinge's PT by 11% in tough market ** J.P.Morgan cuts PT for "underweight"-rated Getinge GETIb.ST by 11% to SEK 165 on continued inflationary headwinds on costs, quality challenges and uncertain order development in China ** The Swedish medical equipment maker's shares are down 2.4% at 0753 GMT ** JPM says the Surgical Workflows unit
G
J
Reuters - vor 4 Wochen

Adidas AG, Crest Nicholson Holdings, Standard Chartered

EUROPE RESEARCH ROUNDUP-Adidas AG, Crest Nicholson Holdings, Standard Chartered June 17 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adidas AG, Crest Nicholson Holdings and Standard Chartered, on Monday. HIGHLIGHTS * Adidas AG ADSGn.DE : JP Morgan raises target price to EUR 250 from EUR 240 * Bellway Plc BWY.L : JP Morgan raises target price to 2,790p from 2,780p * Crest Nicholson Holdings Plc CRST.L : Peel Hunt raises target pr
A
A
B
B
B
C
C
C
E
E
G
H
J
L
O
P
S
S
S
U
A
A
F
U
Reuters - vor 1 Monat

FDA Identified Getinge's Recall Of Vaporizer Sevoflurane Maquet Filling As Class I Recall

BRIEF-FDA Identified Getinge's Recall Of Vaporizer Sevoflurane Maquet Filling As Class I Recall June 13 (Reuters) - Getinge AB GETIb.ST : FDA:GETINGE RECALLS VAPORIZER SEVOFLURANE MAQUET FILLING FOR RISK OF PATIENT AND HEALTH CARE PROFESSIONAL EXPOSURE TO TOXIC CHEMICAL HYDROGEN FLUORIDE FDA: IDENTIFIED GETINGE'S RECALL OF VAPORIZER SEVOFLURANE MAQ
G
Reuters - vor 1 Monat

Getinge Granted U.S. FDA 510(K) Clearance For Its Innovative Clinical Decision Support Software Talis +Acg

BRIEF-Getinge Granted U.S. FDA 510(K) Clearance For Its Innovative Clinical Decision Support Software Talis +Acg June 12 (Reuters) - Getinge AB GETIb.ST : GETINGE: GRANTED U.S. FDA 510(K) CLEARANCE FOR ITS INNOVATIVE CLINICAL DECISION SUPPORT SOFTWARE TALIS +ACG Source text for Eikon: [ID:] Further company coverage: [GETIb.ST]
G
Reuters - vor 2 Monaten

Getinge Sees Acute Care Therapies 2024-2028 Net Sales Organic Growth Of 3-5%

BRIEF-Getinge Sees Acute Care Therapies 2024-2028 Net Sales Organic Growth Of 3-5% May 15 (Reuters) - Getinge AB GETIb.ST : GETINGE CEO ON ACUTE CARE THERAPIES UNIT: PROJECTS ORGANIC GROWTH IN NET SALES OF 3-5% IN 2024-2028 GETINGE CEO ON LIFE SCIENCE UNIT: PROJECTS ORGANIC GROWTH IN NET SALES OF 6-10% IN 2024-2028 GETINGE CEO ON SURGICAL WORKFLOWS
G
Reuters - vor 2 Monaten

Getinge heart device quality issues weigh as co issues new outlook target

BUZZ-Getinge heart device quality issues weigh as co issues new outlook target ** Shares in Getinge GETIb.ST fall 8% after the medical equipment maker issues new midterm guidance , but says finances will continue to be negatively impacted by ongoing quality issues with its heart devices until new products are launched ** The company said it targets over 12% growth on average in its adjusted EPS for 2024-2028, compared to its previous target for over 10% growth in EPS for 2022-2025 ** "New mid-te
G
J
Reuters - vor 2 Monaten

Getinge limits sale of heart devices in the US after FDA warning

Getinge limits sale of heart devices in the US after FDA warning May 15 (Reuters) - Sweden's Getinge GETIb.ST will limit sales of some of its heart products in the U.S., the medical equipment maker said late on Tuesday, after recent advice from the U.S. Food and Drug Administration (FDA) to move away from its devices. "We have decided to immediately pause promotional activities of the Cardiohelp System and Cardiosave Intra-Aortic Balloon Pump in the U.S.
G
Reuters - vor 2 Monaten

Getinge Says Financial Target 2024-2028 Is Adjusted EPS Growth Of Above 12% On Average

BRIEF-Getinge Says Financial Target 2024-2028 Is Adjusted EPS Growth Of Above 12% On Average May 14 (Reuters) - Getinge AB GETIb.ST : GETINGE'S FINANCIAL TARGET 2024-2028: ADJUSTED EPS GROWTH OF ABOVE 12% ON AVERAGE FOR 2024, GETINGE REPEATS ITS GUIDANCE OF 2-5% ORGANIC GROWTH IN NET SALES AND 3-5% GROWTH FROM ACQUIRED UNITS DOES NOT PROVIDE ANY AN
G
Reuters - vor 2 Monaten

Medical gear maker Getinge falls after FDA issues safety warning

BUZZ-Medical gear maker Getinge falls after FDA issues safety warning Adds company comment in 3rd bullet, updates shares ** Shares in Getinge GETIb.ST drop about 7% after U.S. FDA issued a warning on the safety of two of the Swedish medical equipment maker's heart devices ** FDA advised healthcare facilities to switch from Getinge's heart devices amid safety concerns ** " We take this very seriously and have an ongoing dialogue with the FDA on how to best address this," says Elin Frostehav, Pres
G
S
Reuters - vor 2 Monaten

STOXX 600 closes at record high on earnings, rate cut optimism

UPDATE 2-STOXX 600 closes at record high on earnings, rate cut optimism For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window. Rio Tinto considered bid for BHP-target Anglo American -report Green energy production in Italy boosts Enel's Q1 results Medical gear maker Getinge plummets after FDA's safety warning Italy industry output posts unexpected fall in March Updated at 1552 GMT By Ankika Biswas and Johann M Cherian May 10 (Reuters) - Europe
E
G
R
S
S
Z
A
R
E
F
G
Reuters - vor 2 Monaten

New records for STOXX 600, FTSE 100 and DAX; CAC closing in on fresh peak

LIVE MARKETS-New records for STOXX 600, FTSE 100 and DAX; CAC closing in on fresh peak STOXX 600 up 0.6% to new peak DAX and FTSE also at records Wall St futures inch up Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com NEW RECORDS FOR STOXX 600, FTSE 100 AND DAX; CAC CLOSING IN ON FRESH PEAK The pan-European benchmark STOXX 600 .STOXX hit a new intraday record on Friday and is hea
G
E
F
U
G
Reuters - vor 2 Monaten

Medical gear maker Getinge plummets after FDA issues safety warning

BUZZ-Medical gear maker Getinge plummets after FDA issues safety warning ** Shares in Getinge GETIb.ST drop about 8% after U.S. FDA issued a warning on the safety of two of the Swedish medical equipment maker's heart devices ** FDA advised healthcare facilities to switch from Getinge's heart devices amid safety concerns ** Getting did not immediately reply to an emailed request for comment and could not be reached for comment by phone ** Kepler Cheuvreux, via Swedbank Aktiellt, says that while n
G
S
Reuters - vor 2 Monaten

US FDA advises healthcare facilities to switch from Getinge's heart devices

UPDATE 2-US FDA advises healthcare facilities to switch from Getinge's heart devices Adds details in paragraphs 5 & 6, background throughout May 8 (Reuters) - The U.S Food and Drug Administration (FDA) on Wednesday advised healthcare facilities to move away from using Getinge's GETIb.ST heart devices in patients as they faced safety and quality concerns despite a string of recalls.
G
Reuters - vor 2 Monaten

US FDA recommends healthcare providers switch from Getinge's heart devices

US FDA recommends healthcare providers switch from Getinge's heart devices May 8 (Reuters) - The U.S Food and Drug Administration on Wednesday recommended healthcare facilities transition away from using Getinge's GETIb.ST heart devices as they continued to have safety and quality concerns. Reporting by Sriparna Roy in Bengaluru; Editing by Shailes
G
Reuters - vor 3 Monaten

Adriatic Metals, Diageo, GB Group

EUROPE RESEARCH ROUNDUP-Adriatic Metals, Diageo, GB Group April 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Adriatic Metals, Diageo and GB Group, on Tuesday. HIGHLIGHTS * Adriatic Metals Plc ADT1.L : Stifel raises target price to 275p from 250p * Diageo Plc DGE.L : Morgan Stanley cuts target price to 2400p from 2430p * GB Group Plc GBGP.L : Peel Hunt raises target price to 360p from 340p * H&M HMb.ST : Morgan Stanley raises
A
B
B
D
D
D
G
H
I
L
P
H
G
Reuters - vor 3 Monaten

Getinge Sees FY 2024 Quality-Related Costs At About Half Of Costs In 2023

BRIEF-Getinge Sees FY 2024 Quality-Related Costs At About Half Of Costs In 2023 April 22 (Reuters) - Getinge AB GETIb.ST : GETINGE CEO: HEART BALLOON PUMP BACKLOG GRADUALLY REDUCING, BUT SIGNIFICANT BACKLOG STILL GETINGE CFO: FAIR ASSUMPTION THAT FY 2024 COSTS FOR QUALITY IMPROVEMENTS WOULD BE ABOUT HALF OF QUALITY-RELATED COSTS IN TO 2023 GETINGE
G
Reuters - vor 3 Monaten

Medical gear maker Getinge beats profit expectations, shares jump

UPDATE 3-Medical gear maker Getinge beats profit expectations, shares jump Updates share reaction in paragraph 2, adds CEO, CFO comments in paragraphs 5, 9, 11 By Greta Rosen Fondahn and Elsa Ohlen April 22 (Reuters) - Medical equipment maker Getinge GETIb.ST reported a smaller than expected drop in first-quarter core profit on Monday, as new orders offset the costs of resolving prolonged problems with its product packaging and heart products.
G
J

Konditionen

Beliebte Finanzwerte

Rechtlicher Hinweis: Die Unternehmen der XM Group bieten Dienstleistungen ausschließlich zur Ausführung an sowie Zugang zu unserer Online-Handelsplattform. Durch diese können Personen die verfügbaren Inhalte auf oder über die Internetseite betrachten und/oder nutzen. Eine Änderung oder Erweiterung dieser Regelung ist nicht vorgesehen und findet nicht statt. Der Zugang wird stets geregelt durch folgende Vorschriften: (i) Allgemeine Geschäftsbedingungen; (ii) Risikowarnungen und (iii) Vollständiger rechtlicher Hinweis. Die bereitgestellten Inhalte sind somit lediglich als allgemeine Informationen zu verstehen. Bitte beachten Sie, dass die Inhalte auf unserer Online-Handelsplattform keine Aufforderung und kein Angebot zum Abschluss von Transaktionen auf den Finanzmärkten darstellen. Der Handel auf Finanzmärkten birgt ein hohes Risiko für Ihr eingesetztes Kapital.

Sämtliche Materialien, die auf unserer Online-Handelsplattform veröffentlicht sind, dienen ausschließlich dem Zweck der Weiterbildung und Information. Die Materialien beinhalten keine Beratung und Empfehlung im Hinblick auf Finanzen, Anlagesteuer oder Handel und sollten nicht als eine dahingehende Beratung und Empfehlung aufgefasst werden. Zudem enthalten die Materialien keine Aufzeichnungen unserer Handelspreise sowie kein Angebot und keine Aufforderung für jegliche Transaktionen mit Finanzinstrumenten oder unverlangte Werbemaßnahmen für Sie zum Thema Finanzen. Die Materialien sollten auch nicht dahingehend aufgefasst werden.

Alle Inhalte von Dritten und die von XM bereitgestellten Inhalte sowie die auf dieser Internetseite zur Verfügung gestellten Meinungen, Nachrichten, Forschungsergebnisse, Analysen, Kurse, sonstigen Informationen oder Links zu Seiten von Dritten werden ohne Gewähr bereitgestellt. Sie sind als allgemeine Kommentare zum Marktgeschehen zu verstehen und stellen keine Anlageberatung dar. Soweit ein Inhalt als Anlageforschung aufgefasst wird, müssen Sie beachten und akzeptieren, dass der Inhalt nicht in Übereinstimmung mit gesetzlichen Bestimmungen zur Förderung der Unabhängigkeit der Anlageforschung erstellt wurde. Somit ist der Inhalt als Werbemitteilung unter Beachtung der geltenden Gesetze und Vorschriften anzusehen. Bitte stellen Sie sicher, dass Sie unseren Hinweis auf die nicht unabhängige Anlageforschung und die Risikowarnung im Hinblick auf die vorstehenden Informationen gelesen und zur Kenntnis genommen haben, die Sie hier finden.

Risikowarnung: Es bestehen Risiken für Ihr eingesetztes Kapital. Gehebelte Produkte sind nicht für alle Anleger geeignet. Bitte beachten Sie unseren Risikohinweis.